Kurs
+2,94%
Likviditet
0,09 MSEK
Prenumeration
Kalender
Tid* | ||
2025-11-05 | 08:00 | Kvartalsrapport 2025-Q3 |
2025-08-20 | 08:00 | Kvartalsrapport 2025-Q2 |
2025-05-07 | 08:00 | Kvartalsrapport 2025-Q1 |
2025-02-06 | 08:00 | Bokslutskommuniké 2024 |
2024-11-06 | - | Kvartalsrapport 2024-Q3 |
2024-08-21 | - | Kvartalsrapport 2024-Q2 |
2024-06-11 | - | X-dag ordinarie utdelning SPAGO 0.00 SEK |
2024-06-10 | - | Årsstämma |
2024-05-02 | - | Kvartalsrapport 2024-Q1 |
2024-02-07 | - | Bokslutskommuniké 2023 |
2023-11-03 | - | Kvartalsrapport 2023-Q3 |
2023-10-31 | - | Extra Bolagsstämma 2023 |
2023-07-31 | - | Kvartalsrapport 2023-Q2 |
2023-05-11 | - | X-dag ordinarie utdelning SPAGO 0.00 SEK |
2023-05-10 | - | Årsstämma |
2023-05-09 | - | Kvartalsrapport 2023-Q1 |
2023-02-02 | - | Bokslutskommuniké 2022 |
2022-11-08 | - | Kvartalsrapport 2022-Q3 |
2022-08-24 | - | Kvartalsrapport 2022-Q2 |
2022-05-19 | - | X-dag ordinarie utdelning SPAGO 0.00 SEK |
2022-05-18 | - | Årsstämma |
2022-04-27 | - | Kvartalsrapport 2022-Q1 |
2022-02-02 | - | Bokslutskommuniké 2021 |
2021-11-10 | - | Kvartalsrapport 2021-Q3 |
2021-08-24 | - | Kvartalsrapport 2021-Q2 |
2021-05-06 | - | X-dag ordinarie utdelning SPAGO 0.00 SEK |
2021-05-05 | - | Årsstämma |
2021-04-28 | - | Kvartalsrapport 2021-Q1 |
2021-02-02 | - | Bokslutskommuniké 2020 |
2021-01-15 | - | Extra Bolagsstämma 2021 |
2020-11-10 | - | Kvartalsrapport 2020-Q3 |
2020-08-24 | - | Kvartalsrapport 2020-Q2 |
2020-05-29 | - | X-dag ordinarie utdelning SPAGO 0.00 SEK |
2020-05-28 | - | Årsstämma |
2020-04-29 | - | Kvartalsrapport 2020-Q1 |
2020-01-30 | - | Bokslutskommuniké 2019 |
2019-11-13 | - | Extra Bolagsstämma 2019 |
2019-11-13 | - | Kvartalsrapport 2019-Q3 |
2019-05-09 | - | X-dag ordinarie utdelning SPAGO 0.00 SEK |
2019-05-08 | - | Årsstämma |
2019-04-25 | - | Kvartalsrapport 2019-Q1 |
2019-01-30 | - | Bokslutskommuniké 2018 |
2018-11-08 | - | Kvartalsrapport 2018-Q3 |
2018-08-27 | - | Kvartalsrapport 2018-Q2 |
2018-05-17 | - | X-dag ordinarie utdelning SPAGO 0.00 SEK |
2018-05-16 | - | Årsstämma |
2018-04-25 | - | Kvartalsrapport 2018-Q1 |
2018-02-14 | - | Bokslutskommuniké 2017 |
2017-11-08 | - | Kvartalsrapport 2017-Q3 |
2017-09-22 | - | Extra Bolagsstämma 2017 |
2017-08-25 | - | Kvartalsrapport 2017-Q2 |
2017-05-18 | - | X-dag ordinarie utdelning SPAGO 0.00 SEK |
2017-05-17 | - | Årsstämma |
2017-04-26 | - | Kvartalsrapport 2017-Q1 |
2017-02-14 | - | Bokslutskommuniké 2016 |
2016-11-08 | - | Kvartalsrapport 2016-Q3 |
2016-08-26 | - | Kvartalsrapport 2016-Q2 |
2016-05-12 | - | X-dag ordinarie utdelning SPAGO 0.00 SEK |
2016-05-11 | - | Årsstämma |
2016-04-27 | - | Kvartalsrapport 2016-Q1 |
2016-02-12 | - | Bokslutskommuniké 2015 |
2015-11-12 | - | Extra Bolagsstämma 2015 |
2015-11-06 | - | Kvartalsrapport 2015-Q3 |
2015-08-27 | - | Kvartalsrapport 2015-Q2 |
2015-05-06 | - | X-dag ordinarie utdelning SPAGO 0.00 SEK |
2015-05-05 | - | Årsstämma |
2015-04-29 | - | Kvartalsrapport 2015-Q1 |
2015-02-20 | - | Bokslutskommuniké 2014 |
2014-11-14 | - | Kvartalsrapport 2014-Q3 |
2014-08-27 | - | Kvartalsrapport 2014-Q2 |
2014-04-30 | - | X-dag ordinarie utdelning SPAGO 0.00 SEK |
2014-04-29 | - | Årsstämma |
2014-04-29 | - | Extra Bolagsstämma 2014 |
2014-04-29 | - | Kvartalsrapport 2014-Q1 |
2014-02-21 | - | Bokslutskommuniké 2013 |
2013-10-29 | - | Kvartalsrapport 2013-Q3 |
2013-08-29 | - | Kvartalsrapport 2013-Q2 |
2013-05-24 | - | Kvartalsrapport 2013-Q1 |
2013-04-25 | - | Årsstämma |
2013-02-22 | - | Bokslutskommuniké 2012 |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
Spago Nanomedical AB (publ) will present a poster summarizing its platform technology for precision imaging and therapy at the scientific conference ACS Spring 2022, which is held digitally on March 20-24. The poster presentation is scheduled for March 22, 4.00-6.00 PM CET.
The poster, titled Novel nano polymeric tools for cancer diagnosis and treatment, will be presented by Dr Rahma Abouhany and Dr Oskar Axelsson of Spago Nanomedical.
The poster summarizes the chemistry and properties of Spago Nanomedical’s proprietary polymer platform with functional nanoparticles for physiological accumulation in tumour tissue. Furthermore the poster presents results of patient imaging from the clinical study SPAGOPIX-01 with the company’s leading product candidate SN132D for precision MR imaging, as well as preclinical efficacy results of the leading candidate drug 177Lu-SN201 for targeted radionuclide therapy of solid tumors.
Presentation details
Poster title: Novel nano polymeric tools for cancer diagnosis and treatment
Division: Division of Polymeric Materials Science and Engineering for Biomedical Applications
Session: PMSE/POLY Poster Session
Date: 4.00-6.00 PM CET, March 22, 2022
For further information, please contact Mats Hansen, CEO Spago Nanomedical AB, +46 46 811 88, mats.hansen@spagonanomedical.se
Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of solid tumors. Spago Nanomedical´s share is listed on Nasdaq First North Growth Market (ticker: SPAGO). For further information, see www.spagonanomedical.se.
FNCA Sweden AB is the Certified Adviser of the company, +46 8 528 00 399, info@fnca.se.